Organ-confined prostate cancer: Are we moving towards more or less radical surgical intervention? - Abstract

Treatment possibilities for clinically localised prostate cancer include radical prostatectomy (RP), external beam radiotherapy, brachytherapy, focal therapy and active surveillance.

Conflicting and methodologically flawed observational data from the last two decades have led to uncertainty as to the best oncological option. However, recently, there has been a series of high-quality studies that point to disease specific and overall survival advantages for those men undergoing RP. This article reviews the latest evidence and argues that at the current time, RP must be considered the gold standard treatment for the majority of men with clinically localised prostate cancer.

Written by:
Stevens DJ, Sharma NL, Tewari AK, Kirby R, Sooriakumaran P.   Are you the author?
Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.

Reference: Curr Urol Rep. 2015 May;16(5):504.
doi: 10.1007/s11934-015-0504-z

PubMed Abstract
PMID: 25773349 Prostate Cancer Section


Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.